ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNally, E
Right arrow Articles by McNicholas, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNally, E
Right arrow Articles by McNicholas, W.
Eur Respir J 1993; 6: 1353-1356
Copyright © ERS Journals Ltd 1993


Original Articles

Reversible hypercapnia in acute exacerbations of chronic obstructive pulmonary disease (COPD)

E McNally, M Fitzpatrick, S Bourke, R Costello, and WT McNicholas

We prospectively studied emergency hospitalizations due to acute exacerbations of chronic obstructive pulmonary disease (COPD) among 74 hypercapnic patients, in order to determine factors which predict reversal to normocapnia as a result of therapy. Clinical, arterial blood gas and pulmonary function data on presentation were compared to predischarge values among those 58 patients who survived the admission. Patients were divided into those who reverted to normocapnia (reversible, 40% of surviving patients), and those who remained hypercapnic (chronic, 60% of surviving patients). Reversible patients had higher admission arterial oxygen tension (PaO2) levels than those with chronic hypercapnia (6.4 +/- 1.3 kPa (mean +/- SD), as compared to 5.7 +/- 1.1 kPa) better pulmonary function (forced expiratory volume in one second (FEV1) 35 +/- 16% predicted, as compared to 26 +/- 7.9), and a lower prevalence of cor pulmonale (30% as compared to 63% of patients). No admission variable(s) distinguished individual patients as reversible or chronic hypercapnic, and, in particular, admission arterial carbon dioxide tension (PaCO2) and pH levels were similar in both groups. Furthermore, there were no differences between survivors and those 16 patients who died during the admission, apart from a higher urea level among those who died. These findings suggest that reversible patients have milder underlying disease than those with chronic hypercapnia. Our data establish the high prevalence of reversible hypercapnia among patients hospitalized with exacerbations of COPD, and, furthermore, indicate that patients who are normocapnic in the stable state can develop similar levels of hypercapnia during exacerbations as those with chronic hypercapnia.


This article has been cited by other articles:


Home page
ChestHome page
M. Vitacca, L. Bianchi, L. Barbano, M. Ziliani, and N. Ambrosino
Effects of Acute on Chronic Respiratory Failure on Hypercapnia and 3-Month Survival
Chest, September 1, 2005; 128(3): 1209 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C.M. Roberts, I. Ryland, D. Lowe, Y. Kelly, C.E. Bucknall, and M.G. Pearson
Audit of acute admissions of COPD: standards of care and management in the hospital setting
Eur. Respir. J., March 1, 2001; 17(3): 343 - 349.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. W. S. Hoo, N. Hakimian, and S. M. Santiago
Hypercapnic Respiratory Failure in COPD Patients* : Response To Therapy
Chest, January 1, 2000; 117(1): 169 - 177.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the European Respiratory Society.